Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals

Diabetes and Metabolism

Volumn 34, Issue 2, 2008, Pages 183-184

  Karelis, A D ^a   Rabasa Lhoret, R ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BODY FAT; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HEALTH STATUS; HUMANS; OBESITY; TRIGLYCERIDES;

EID: 42249098249     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.11.004     Document Type: Letter

References (8)

1. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
2. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90 (2005) 4145-4150
3. Karelis A.D., Brochu M., and Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)?. Diabetes Metab 30 (2004) 569-572
4. Shin M.J., Hyun Y.J., Kim O.Y., Kim J.Y., Jang Y., and Lee J.H. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30 (2006) 1529-1534
5. Ridker P.M., Wilson P.W., and Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 109 (2004) 2818-2825
6. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 (2006) 21-29
7. Bassuk S.S., Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29 (2004) 439-493
8. Meigs J.B., Wilson P.W., Fox C.S., Vasan R.S., Nathan D.M., Sullivan L.M., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91 (2006) 2906-2912